MGSC14H3 Lecture Notes - Lecture 9: Caffeine, Deontological Ethics, Sustainable Development
Document Summary
The aspirin market is basically an oligopoly market with 4 main players: american home pharmacy with anacin, bristol-myers (mai-ur) with bufferin, Johnson and johnson with st. joseph, and sterling (stur) with bayer (be-uh). The key point is that they are all aspirin a medicine for pain reliever, so technically they contain the same ingredients. Another way to say is that they can only compete with each other over price or advertisements: fast, fast relief. The greatest pain fighter ever discovered, recommended by doctors : twice as fast as aspirin (bufferin, faster than other leading pain relief tablets (st joseph, bayer: fastest relief of pain ( bayer) None of these claims have been proven, no evidence provided by any of the companies. Stakeholder analysis: competitors - ethical dilemma - to compete or not to. Forced to make appealing & deceptive ads to attract customers. If companies choose not to make such ads, they will be kicked out of the: producers.
